From the Track to the Lab:

FUS mutations often exhibit a younger age

FUS discovery was a landmark achievement

DR. Landers
The Landers Lab & The Grand PrixThe Landers Lab at UMass Chan Medical School, led by Dr. John Landers, is a powerhouse in the global fight against Amyotrophic Lateral Sclerosis (ALS). While their groundbreaking work happens at the microscope, its momentum is often fueled by community-driven events like the Go Kart Grand Prix.The Breakthrough: Identifying the FUS GeneThe lab’s most significant milestone was identifying mutations in the FUS (Fused in Sarcoma) gene. This discovery transformed our understanding of familial ALS (fALS):Impact: $FUS$ mutations are responsible for 4–6% of familial cases.Unique Profile: These mutations are frequently linked to an earlier onset of the disease, making the search for a cure even more urgent.Precision Science: Using a mix of linkage analysis and high-throughput sequencing, the lab mapped the genetic blueprint that leads to motor neuron degeneration.Racing for a Cure: The Go Kart Grand PrixThe "Fight Against ALS" Go Kart Grand Prix isn't just a race—it’s a vital funding vehicle for the Landers Lab. This high-speed event brings together researchers, families, and supporters to:Fund Innovation: Proceeds directly support the expensive high-throughput sequencing required to find the next "FUS" or "KIF5A" gene.Bridge the Gap: It allows the scientists, including Dr. Landers himself, to connect with the families who benefit from their research.Drive Awareness: Just as the lab looks for speed in genetic processing, the Grand Prix symbolizes the race against time to find a cure for neurodegenerative diseases.

Read More | Video
NFL Players Firefighters universities Live Streaming